Posted by Bay Area News Group blog editor on October 8th, 2008 at 2:00 pm | Categorized as 1 | Tagged as Accuray, Biotechnology, Medical devices
Accuray, the Sunnyvale developer of robotic radiosurgery systems says that it will install its first CyberKnife system in the Middle East at the King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia. (Logo to the left.)
The medical equipment, to be used by the newly established King Faisal Cancer Centre, Read the rest of this entry »
Leave a comment
Posted by Bay Area News Group blog editor on September 19th, 2008 at 5:03 pm | Categorized as 1 | Tagged as Biotechnology, IPOs
Fluidigm, the South San Francisco biotech company that registered its initial public offering with the SEC back in April, is set to push it out to investors next week, according to Renaissance Capital. At least its investment banker underwriting the offering, Morgan Stanley, is still standing.
The company, which supplies what it calls integrated fluidic circuits — nanoscale devices that enable its life science customers to perform thousands of sophisticated biochemical measurements on samples smaller than the content of a single cell — is offering 5.3 million shares to the public for the first time. It has set a price range for the offering Read the rest of this entry »
Leave a comment
Posted by Bay Area News Group blog editor on September 9th, 2008 at 1:13 pm | Categorized as 1 | Tagged as Biotechnology, Mergers and Acquisitions, Pharsight
Pharsight, the Mountain View supplier of software and services to optimize the drug development process, agreed Tuesday to be acquired by Tripos, a St. Louis provider of technologies to improve molecular level life-science research, for $5.50 a share, or about $57 million in cash, according to a regulatory filing. The price was nearly a third higher than Pharsight’s closing price Monday before the deal was announced.
Pharsight’s biggest shareholder are entities associated with Read the rest of this entry »
Leave a comment
Posted by Bay Area News Group blog editor on June 15th, 2008 at 6:56 pm | Categorized as 1 | Tagged as Biotechnology, Stanford
Speaking this weekend to the graduating class of the Stanford School of Medicine , which turned 100 this year, Nobel laureate Roger Kornberg, a professor of structural biology at the school urged the graduates to consider dedicating themselves to research.
Kornberg (pictured), who won the 2006 Nobel Prize in Chemistry for his discoveries of how DNA is converted into RNA — a process known as transcription — has been meeting with national lawmakers to discuss the importance of continuing to fund scientific research. Here are excerpts of his remarks Saturday: Read the rest of this entry »
Leave a comment